Innovative strategy reduces tumor growth and strengthens the immune system against tumor cells. Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumour is still responsible for one in eight male cancer deaths in Austria alone. An international research team led by MedUni Vienna has now investigated a new strategy for the development of treatment options that not only slow tumour growth, but also stimulate the immune system to combat tumour cells. The results of the study have just been published in the top journal Molecular Cancer.
The scientific team focused its investigations on the GP130 signalling pathway, which researchers expect to have a major potential in the fight against cancer.
The background: th...
Read More
Recent Comments